Search research articles
Contact Us
Filters
Showing results (211-220 of 243) with videos related to
Page
of 25
Sort By:
Cancer Research
|
November 23, 2016
Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer
Vikram B Wali, Casey G Langdon, Matthew A Held, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 6, 2016
PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer
Jaekwang Jeong, Joshua N VanHouten, Pamela Dann, et al.
Addictive Behaviors Reports
|
December 10, 2025
Associations between cannabis use frequency and suicidal thoughts and behaviors: A clinical longitudinal sibling study
Elisa F Stern, Jarrod M Ellingson, Jonathan D Schaefer, et al.
JACC. Cardiovascular Interventions
|
April 28, 2009
A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality
Harlan M Krumholz, Elizabeth H Bradley, Brahmajee K Nallamothu, et al.
BMC Research Notes
|
August 20, 2008
Contemporary evidence: baseline data from the D2B Alliance
Elizabeth H Bradley, Brahmajee K Nallamothu, Amy F Stern, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 28, 2021
Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants
Sarah D Lichenstein, Nick Manco, Lora M Cope, et al.
Pigment Cell & Melanoma Research
|
April 10, 2015
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors
Casey G Langdon, Matthew A Held, James T Platt, et al.
Oncotarget
|
October 21, 2015
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells
Casey G Langdon, Norbert Wiedemann, Matthew A Held, et al.
Cancer Discovery
|
December 15, 2012
Genotype-selective combination therapies for melanoma identified by high-throughput drug screening
Matthew A Held, Casey G Langdon, James T Platt, et al.
Joint Commission Journal on Quality and Patient Safety
|
February 27, 2009
The door-to-balloon alliance for quality: who joins national collaborative efforts and why?
Elizabeth H Bradley, Brahmajee K Nallamothu, Amy F Stern, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 243) with videos related to
Sort By:
Page
of 25
Cancer Research
|
November 23, 2016
Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer
Vikram B Wali, Casey G Langdon, Matthew A Held, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 6, 2016
PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer
Jaekwang Jeong, Joshua N VanHouten, Pamela Dann, et al.
Addictive Behaviors Reports
|
December 10, 2025
Associations between cannabis use frequency and suicidal thoughts and behaviors: A clinical longitudinal sibling study
Elisa F Stern, Jarrod M Ellingson, Jonathan D Schaefer, et al.
JACC. Cardiovascular Interventions
|
April 28, 2009
A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality
Harlan M Krumholz, Elizabeth H Bradley, Brahmajee K Nallamothu, et al.
BMC Research Notes
|
August 20, 2008
Contemporary evidence: baseline data from the D2B Alliance
Elizabeth H Bradley, Brahmajee K Nallamothu, Amy F Stern, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 28, 2021
Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants
Sarah D Lichenstein, Nick Manco, Lora M Cope, et al.
Pigment Cell & Melanoma Research
|
April 10, 2015
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitors
Casey G Langdon, Matthew A Held, James T Platt, et al.
Oncotarget
|
October 21, 2015
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells
Casey G Langdon, Norbert Wiedemann, Matthew A Held, et al.
Cancer Discovery
|
December 15, 2012
Genotype-selective combination therapies for melanoma identified by high-throughput drug screening
Matthew A Held, Casey G Langdon, James T Platt, et al.
Joint Commission Journal on Quality and Patient Safety
|
February 27, 2009
The door-to-balloon alliance for quality: who joins national collaborative efforts and why?
Elizabeth H Bradley, Brahmajee K Nallamothu, Amy F Stern, et al.
Page
of 25